1.      Bamji M, Stone RK, Kaul A, et al. Palpable lymph nodes in healthy newborns and infants. Pediatrics. 1986;78(4):573-575.

2.      Behrens EM, Beukelman T, Gallo L, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343-348.

3.      Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004;364(9433):533-544. doi:10.1016/S0140-6736(04)16814-1

4.      Cameron D, Stetson A, Blase J, et al. Pediatric Lymphadenopathy. Adv Pediatr. 2025;72(1):93-102. doi:10.1016/j.yapd.2025.03.008

5.      Chang SSY, Xiong M, How CH, et al. An approach to cervical lymphadenopathy in children. Singapore Med J. 2020;61(11):569-577. doi:10.11622/smedj.2020151

6.      Chiappini E, Camaioni A, Benazzo M, et al. Development of an algorithm for the management of cervical lymphadenopathy in children: consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society of Pediatric Otorhinolaryngology. Expert Rev Anti Infect Ther. 2015;13(12):1557-1567. doi:10.1586/14787210.2015.1096777

7.      Clemente AS, Baker CJ, Healy CM. Cervical Lymphadenitis. In: Cherry JD, Kaplan SL, Harrison GJ, Steinbach WJ, Hotez PJ, Williams JV. Pediatric Infectious Diseases, 9th ed. Philedelphia, PA: Elsevier;2025:129-139.

8.      Darré T, Doukouré B, Djiwa T, et al. Cervical lymphadenopathy of Togolese children in a tropical context: clinicopathological study. Trop Doct. 2021;51(1):96-99. doi:10.1177/0049475520947882

9.      Deosthali A, Donches K, DelVecchio M, et al. Etiologies of Pediatric Cervical Lymphadenopathy: A Systematic Review of 2687 Subjects. Glob Pediatr Health. 2019;6:2333794X19865440. doi:10.1177/2333794X19865440

10.  Expert Panel on Neurologic Imaging:, Aulino JM, Kirsch CFE, et al. ACR Appropriateness Criteria^® Neck Mass-Adenopathy. J Am Coll Radiol. 2019;16(5S):S150-S160. doi:10.1016/j.jacr.2019.02.025

11.  Freeman AM, Matto P. Lymphadenopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; February 20, 2023.

12.  Gosche JR, Vick L. Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg. 2006;15(2):99-106. doi:10.1053/j.sempedsurg.2006.02.007

13.  Grant CN, Aldrink J, Lautz TB, et al. Lymphadenopathy in children: A streamlined approach for the surgeon - A report from the APSA Cancer Committee. J Pediatr Surg. 2021;56(2):274-281. doi:10.1016/j.jpedsurg.2020.09.058

14.  Hendry AJ, Dey A, Beard FH, et al. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine. Commun Dis Intell Q Rep. 2016;40(4):E470-E474. Published 2016 Dec 24. doi:10.33321/cdi.2016.40.52

15.  Herzog LW. Prevalence of lymphadenopathy of the head and neck in infants and children. Clin Pediatr (Phila). 1983;22(7):485-487. doi:10.1177/000992288302200703

16.  Hoffmann C, Oksenhendler E, Littler S, et al. The clinical picture of Castleman disease: a systematic review and meta-analysis. Blood Adv. 2024;8(18):4924-4935. doi:10.1182/bloodadvances.2024013548

17.  Ingolfsdottir M, Balle V, Hahn CH. Evaluation of cervical lymphadenopathy in children: advantages and drawbacks of diagnostic methods. Dan Med J. 2013;60(8):A4667.

18.  Kang HM, Kim JY, Choi EH, et al. Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. J Pediatr. 2016;171:208-12.e1. doi:10.1016/j.jpeds.2015.12.064

19.  Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071-1080. doi:10.1111/bjd.12501

20.  Kawano-Dourado L, Peirera DA, Kawassaki Ade M, et al. Lymphadenopathy and fever in a chef during a stay in Europe. J Bras Pneumol. 2015;41(2):191-195. doi:10.1590/S1806-37132015000004412

21.  Kawasaki T. Arerugi. 1967;16(3):178-222.

22.  Larsson LO, Bentzon MW, Berg Kelly K, et al. Palpable lymph nodes of the neck in Swedish schoolchildren. Acta Paediatr. 1994;83(10):1091-1094. doi:10.1111/j.1651-2227.1994.tb12992.x

23.  Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. 2011;20(13):1345-1355. doi:10.1177/0961203311416694

24.  Lou F, Zhang T, Ming C, Ma J, Wang M, Zeng W. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;34(10):928-931. doi:10.13201/j.issn.2096-7993.2020.10.014

25.  Metterle L, Hatch L, Seminario-Vidal L. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature. Pediatr Dermatol. 2020;37(1):124-129. doi:10.1111/pde.

26.  Moore SW, Schneider JW, Schaaf HS. Diagnostic aspects of cervical lymphadenopathy in children in the developing world: a study of 1,877 surgical specimens. Pediatr Surg Int. 2003;19(4):240-244. doi:10.1007/s00383-002-0771-x

27.  NHS Greater Glasgow and Clyde. Cervical lymphadenopathy: advice for referrers. RHC for Health Professionals. Reviewed November 25, 2024. Accessed May 7, 2026. clinicalguidelines.scot.nhs.uk

28.  Oguz A, Karadeniz C, Temel EA, Citak EC, Okur FV. Evaluation of peripheral lymphadenopathy in children. Pediatr Hematol Oncol. 2006;23(7):549-561. doi:10.1080/08880010600856907

29.  Park JE, Ryu YJ, Kim JY, et al. Cervical lymphadenopathy in children: a diagnostic tree analysis model based on ultrasonographic and clinical findings. Eur Radiol. 2020;30(8):4475-4485. doi:10.1007/s00330-020-06794-w

30.  Park YW. Evaluation of neck masses in children. Am Fam Physician. 1995;51(8):1904-1912.

31.  Ryoo I, Suh S, Lee YH, et al. Comparison of Ultrasonographic Findings of Biopsy-Proven Tuberculous Lymphadenitis and Kikuchi Disease. Korean J Radiol. 2015;16(4):767-775. doi:10.3348/kjr.2015.16.4.767

32.  Sabir S, Daley SF, Huang B. Cat Scratch Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; December 13, 2025.

33.  Sarsu SB, Sahin K. A retrospective evaluation of lymphadenopathy in children in a single center's experience. J Pak Med Assoc. 2016;66(6):654-657.

34.  Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10-45. doi:10.3322/caac.21871

35.  Stanford EF, Levine HM, Cabana MD, et al. Lymphadenopathy: Differential Diagnosis and Indications for Evaluation. Pediatr Rev. 2024;45(8):429-439. doi:10.1542/pir.2023-006291

36.  Şen HS, Ocak S, Yılmazbaş P. Children with cervical lymphadenopathy: reactive or not?. Turk J Pediatr. 2021;63(3):363-371. doi:10.24953/turkjped.2021.03.003

37.  Varona JF, Guerra JM, Guillén V, et al. Isolated cervical lymphadenopathy as unique manifestation of Brucellosis. Scand J Infect Dis. 2002;34(7):538-540. doi:10.1080/003655402320208802

38.  Weinstock MS, Patel NA, Smith LP. Pediatric Cervical Lymphadenopathy. Pediatr Rev. 2018;39(9):433-443. doi:10.1542/pir.2017-0249

39.  Yaris N, Cakir M, Sözen E, et al. Analysis of children with peripheral lymphadenopathy. Clin Pediatr (Phila). 2006;45(6):544-549. doi:10.1177/0009922806290609